Clinical development studies in progress
In collaboration with NanoEcho, two investigator-led clinical development studies on surgical rectal cancer tissue are ongoing. In June 2021, the first one began at Sahlgrenska University Hospital in Gothenburg under the direction of Professor Eva Angenete. In November 2022, the second one began at Skåne University Hospital in Malmö under the direction of Professor Henrik Thorlacius. Experience and input from these clinical development trials are used to evaluate the effectiveness of the existing system and to support the product development of the next system.
Together, these two studies will provide valuable information on system performance – including patients with different tumour positions and different stages of rectal cancer. The studies also provide important information for the design of the upcoming clinical registration trial. The study required to obtain regulatory approval.